Vaccines developed for new Meningitis-B strains

By WEEK Producer

June 18, 2014 Updated Jun 18, 2014 at 7:15 PM CDT

This year there were two separate university outbreaks of Meningitis-B -- a strain of the illness that is not covered in U.S. vaccines.

Now, Novartis and Pfizer have each developed vaccines that protect against Meningitis-B.

They have been granted breakthrough therapy status by the FDA -- which could speed up the agency's consideration of the shots.

Earlier this year Princeton and UC Santa Barbara had Meningitis-B outbreaks.

Health officials brought in European vaccines to help stop the spread of Meningitis-B.

To submit a comment on this article, your email address is required. We respect your privacy and your email will not be visible to others nor will it be added to any email lists.